My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 153

    1.

    Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids.

    Miller AL, Komak S, Webb MS, Leiter EH, Thompson EB.

    Cancer Cell Int. 2007 Nov 28;7:18.PMID: 18045478 [PubMed - in process]Related articlesFree article

    2.

    Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.

    Medh RD, Saeed MF, Johnson BH, Thompson EB.

    Cancer Res. 1998 Aug 15;58(16):3684-93.PMID: 9721879 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Identification of genes leading to glucocorticoid-induced leukemic cell death.

    Thompson EB, Webb MS, Miller AL, Fofanov Y, Johnson BH.

    Lipids. 2004 Aug;39(8):821-5. Review.PMID: 15638253 [PubMed - indexed for MEDLINE]Related articles

    4.

    Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.

    Thompson EB, Johnson BH.

    Recent Prog Horm Res. 2003;58:175-97. Review.PMID: 12795419 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.

    Geley S, Hartmann BL, Hala M, Strasser-Wozak EM, Kapelari K, Kofler R.

    Cancer Res. 1996 Nov 1;56(21):5033-8.PMID: 8895760 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis.

    Hirakawa Y, Nary LJ, Medh RD.

    J Mol Signal. 2009 Sep 2;4:6.PMID: 19725972 [PubMed - in process]Related articlesFree article

    7.

    Gene networks in glucocorticoid-evoked apoptosis of leukemic cells.

    Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG, Thompson EB.

    J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):183-93.PMID: 12943703 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells.

    Ashraf J, Kunapuli S, Chilton D, Thompson EB.

    J Steroid Biochem Mol Biol. 1991 May;38(5):561-8.PMID: 2039752 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.

    Miller AL, Webb MS, Thompson EB.

    Steroids. 2007 Sep;72(9-10):673-81. Epub 2007 May 29.PMID: 17606285 [PubMed - indexed for MEDLINE]Related articles

    10.

    Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia.

    Schwartz JR, Sarvaiya PJ, Vedeckis WV.

    Mol Cell Endocrinol. 2010 Feb 17. [Epub ahead of print]PMID: 20170710 [PubMed - as supplied by publisher]Related articles

    11.

    Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.

    Medh RD, Wang A, Zhou F, Thompson EB.

    Oncogene. 2001 Aug 2;20(34):4629-39.PMID: 11498786 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts.

    Zhou F, Thompson EB.

    Mol Endocrinol. 1996 Mar;10(3):306-16.PMID: 8833659 [PubMed - indexed for MEDLINE]Related articles

    13.

    Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis.

    Medh RD, Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG, Luxon BA, Thompson EB.

    Genomics. 2003 Jun;81(6):543-55.PMID: 12782123 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Calcium-dependent upregulation of E4BP4 expression correlates with glucocorticoid-evoked apoptosis of human leukemic CEM cells.

    Priceman SJ, Kirzner JD, Nary LJ, Morris D, Shankar DB, Sakamoto KM, Medh RD.

    Biochem Biophys Res Commun. 2006 Jun 2;344(2):491-9. Epub 2006 Apr 5.PMID: 16630563 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.

    Hala M, Hartmann BL, Böck G, Geley S, Kofler R.

    Int J Cancer. 1996 Nov 27;68(5):663-8.PMID: 8938150 [PubMed - indexed for MEDLINE]Related articles

    16.

    Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: signaling pathway interactions.

    Garza AS, Miller AL, Johnson BH, Thompson EB.

    Leuk Res. 2009 May;33(5):717-27. Epub 2008 Nov 13.PMID: 19012965 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells.

    Miller AL, Garza AS, Johnson BH, Thompson EB.

    Cancer Cell Int. 2007 Mar 28;7:3.PMID: 17391526 [PubMed]Related articlesFree article

    18.

    Low glucocorticoid receptor (GR), high Dig2 and low Bcl-2 expression in double positive thymocytes of BALB/c mice indicates their endogenous glucocorticoid hormone exposure.

    Boldizsár F, Pálinkás L, Czömpöly T, Bartis D, Németh P, Berki T.

    Immunobiology. 2006;211(10):785-96. Epub 2006 Jul 28.PMID: 17113916 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk